This document provides an overview of fundus fluorescein angiography (FFA). It begins with a brief history of FFA and describes the properties and pharmacokinetics of fluorescein dye. The document outlines the procedure for FFA, including patient positioning, dye injection, and photographing different phases. Normal FFA phases and angiogram patterns are presented, along with examples of abnormal hypofluorescence, hyperfluorescence, and vascular filling defects. The document concludes with brief descriptions of several common retinal conditions visualized on FFA.
2. Brief history
Dye synthesized by Adolf von Baeyer in 1871
Fundus camera introduced by Zeiss in mid-fifties
Chaos and Flocks gave first description of fluorescein angiography
First used in clinical practice by Novotiny and Alvis in 1961
3. Luminescence:
Emission of light from any source other than high temperature
Energy in the form of electromagnetic radiation is absorbed and then
re-emitted at another frequency.
Fluorescence:
Luminescence that is maintained only by continuous excitation
excitation at one wavelength occurs and is emitted immediately
through a longer wavelength.
4. Properties of dye
Physical:
Water soluble crystalline powder
Color: dark red to yellow green
Chemical:
Hydrocarbon: C20H10O5Na2
Molecular wt.: 376.27 kD
5. Fluorescence:
Excitation occurs by light of wavelength between 465 to 490 nm
Emits light of wavelength between 520 to 530 nm
Pharmacokinetics:
Excreted by kidney and liver
Traces may be found for upto 1 week after injection
After i.v. injection, 80% bound to blood proteins
Permeates freely through blood vessels of all tissues except CNS and
retina
Also excreted in human milk
6. Side effects:
Nausea, vomiting
Skin rash, itching
Yellow discoloration of urine for 1st 24 hours
Yellow discoloration of skin, phototoxicity
Gives positive test results for sugar in urine for several days
Anaphylaxis and shock
Painful local reaction in case of extravasation
8. Contraindications
Absolute:
Fluorescein allergy
h/o severe allergic reaction to any allergen
Relative:
Pregnancy
Renal failure
Moderate to severe asthma
Significant cardiac disease
Iodine allergy is NOT a contraindication for FFA
9. procedure
Explain procedure to the patient and obtain informed consent
Full mydriasis
Proper patient positioning
Color photos, red free photos and photos with FA barriers in place taken
before injecting the dye
Injection of dye
11. Injection of dye
Available solutions:
Contain 500 mg of fluorescein
Vials of 10 ml of 5% fluorescein or 5 ml of 10% fluorescein
Also 3 ml of 25% fluorescein solution (750 mg)
Greater the volume, the longer the injection time will be
Smaller the volume, a significant percentage of fluorescein will remain in
the venous dead space between the arm and the heart
For pediatric patients, the dose is adjusted to 7 mg/kg of body weight
12. Scalp vein should be used (23 G)
Ante-cubital vein is preferred
Any vein on dorsum of hand or radial aspect of wrist may be used
Timer started with injection of dye
Rapid injection over 2-3 sec yields better photographs
No extravasation of dye should be allowed
13. Taking fundus photographs
Begin taking the initial transit fluorescein photographs
8 seconds after the beginning of the injection in young patient
12 seconds after injection for older patients
Followed by approximately six photographs at intervals of 1.5 to 2
seconds
Photographs taken as often as every second are not usually necessary
14. If no fluorescein entering and filling the retinal vessels is seen while the six
initial-transit photographs are taken, continue to photograph the fundus
until filling takes place
Also check as to why no fluorescein is present
Control pictures of opposite eye are also taken
Photos during desired phases are taken
Late photos at 10 min and 20 min may be taken
Special emphasis to areas of interest
18. Phase I
Dye enters choroidal circulation 1 sec before retinal
circulation
Also called ‘choroidal flush’
Patchy choroidal filling
Watershed zone between medial and lateral ciliary
arteries
Cilioretinal artery will fill in this phase
Macula remains dark throughout the angiogram
19. Phase II
• Starts 1 sec after phase I
• Retinal arteriolar filing with continuation of
choroidal filling
20. Phase III
• Fluorescein from the venules enters the veins
along their walls
• Flow of fluorescein in the veins is laminar
• The dark central lamina is nonfluorescent
blood that comes from the periphery
• The perifoveal capillary net can be seen
best in young patients with clear ocular
media about 20 to 25 seconds later
• This is called the “peak” phase of the
fluorescein angiogram.
21. Phase IV
• As fluorescein filling increases, the
laminae enlarge and meet
• Complete fluorescence of the retinal
veins.
22. Phase V
• Approximately 30 seconds after injection, the first
high concentration flush of fluorescein begins to
empty from the choroidal and retinal circulations
• The vessels of most normal patients almost
completely empty of fluorescein in approximately
10 minutes
• staining of Bruch’s membrane, the choroid, and
especially the sclera may be visible if the pigment
epithelium is lightly pigmented.
• The disc and adjacent visible sclera remain
hyperfluorescent because of staining
• The lamina cribrosa within the disc also remains
hyperfluorescent because of staining
• the disc stains from the adjacent choriocapillaris,
which normally leaks.
25. blocked fluorescence: If material is visible ophthalmoscopically and
corresponds to the area of hypofluorescenceIf
vascular filling defect : no corresponding blocking material exists
26. Blocked fluorescence
Further the opacification is in front of the fundus, the more it will affect
the overall quality of the photographs
Light scattered from the nonfluorescing opacities is not transmitted
through the barrier filter and has no effect on the angiographic
photograph
When anterior segment and vitreous opacities are present, the angiogram
may be of higher resolution and quality than the color photograph
27. Blocked retinal fluorescence
• blocking material lies in front of the
nerve fiber layer: block both planes of
retinal vessels e.g. subhyaloid
hemorrhage
• Material lies beneath the nerve fiber
layer but within or in front of the
inner nuclear layer: will block only the
retinal capillaries and choroidal vessels
leaving the view of the large retinal
vessels unobstructed e.g. flame shaped
hemorrhage, severe retinal edema
• Material lies deep to the inner nuclear
layer: will not block the retinal vessels
but will block the choroidal vascular
fluorescence e.g. deep intra retinal
hemorrhage
28.
29.
30. Blocked choroidal fluorescence
• Fluid, exudate, hemorrhage, pigment,
scar, and inflammatory material,
accumulates in front of the choroidal
vasculature and deep to the retinal
vasculature
31.
32.
33. Vascular filling defects
complete occlusion or complete atrophy of vascular tissue:
hypofluorescence is complete and lasts throughout the angiogram
Partial obstruction or incomplete vascular atrophy: the vascular
fluorescein filling is delayed or reduced relative to corresponding areas
that fill normally
34. Retinal vascular filling defects:
Can be arterial, venous or capillary
Easily distinguished by phase of angiogram
Correspond to the normal vasculature of the retina
37. Filling defect of disc:
Causes:
Congenital absence of disc tissue e.g. optic pit, optic nerve head coloboma
Atrophy of the disc tissue and its vasculature e.g. optic atrophy
Vascular occlusion e.g. ischemic optic neuropathy
Characterized by early hypofluorescence caused by nonfilling and late
hyperfluorescence due to staining of the involved tissue
38. Choroidal vascular filling defect:
Pigment epithelium depigmented or atrophied in chronic choroidal vascular
filling defects
Loss of ground-glass fluorescence from the choriocapillaris
Filling defect does not correspond to retinal vasculature
Patchy choroidal filling: early hypofluorescence followed by normal filling of
whole choroid 2 – 5 sec later
41. Main causes are
Preinjection fluorescence
Transmitted fluorescence
Abnormal vessels
Leakage
42. Pre injection fluorescence:
Autofluorescence:
emission of fluorescent light from ocular structures in the absence of sodium
fluorescein
Seen in optic disc drusen and astrocytic hahartoma
Pseudoflourescence:
blue exciter and green barrier filters overlap i.e., the blue filter allows the passage
green light or the green barrier filter allows the passage of blue light
Seen from light colored or white fundus change e.g. sclera, exudate, scar tissue,
myelinated nerve fibers, foreign body
43.
44.
45. Transmitted fluorescence:
Also known as pigment epithelial window defect
Occurs due to increased visibility of normal choroidal vasculature
Appears early in angiography, coincidental with choroidal filling
Increases in intensity as dye concentration increases in the choroid
Does not increase in size or shape during the later phase of angiography
Fades and sometimes disappear as the choroid empties of dye at the end of
angiography
46.
47.
48. Abnormal vessels on retina and disc:
tortuosity and dilation
Aneurysms
Neovascularization
Anastomosis
Telangiectasis
tumor vessels
49.
50.
51.
52. Abnormal vessels in choroid:
Subretinal neovascularization: lacy, irregular, and nodular hyperfluorescence
Tumor
53.
54.
55. Leak:
Late extravascular hyperfluoresence which may be normal
fluorescence of the disc margins from the surrounding choriocapillaris
Fluorescence of the lamina cribrosa
fluorescence of the sclera at the disc margin if the retinal pigment epithelium
terminates away from the disc, as in an optic crescent
Fluorescence of the sclera when the pigment epithelium is lightly pigmented
56. Disc leak:
Normal to some extent
Disc edema shows initial hyperfluorescence due to dilated capillaries followed by
leakage of dye
Vitreous leak:
Retinal neovascularization: localized snowball like appearance
Intraocular inflammation: diffuse white haze
Tumor: localized to area of tumor
57. Retinal leak
Cystoid edema: dye lies in small loculated pockets
Leakage of large retinal vessels leads to perivascular staining
Seen in traction, occlusion and inflammation
Choroidal leak
Pooling: accumulation of dye in anatomic spaces such as under areas of
detachment as in CSR, and PED
Staining: accumulation of dye in tissue and material such as sclera, RPE and drusen
58.
59.
60. Stargardts Disease exhibits a ‘silent choroid’ and a central bulls-eye
fluorescence pattern in the macula
APMPPE demonstrates a characteristic ‘block early, stain late’ pattern
75. Bibliography
Fundus fluorescein angiography in Retina. Ryan
Acquired macular disorders in Clinical Ophthalmology. Kanski and Bowling
Albert and jacobiec’s principles and practices of ophthalmology